trending Market Intelligence /marketintelligence/en/news-insights/trending/5n-9Lk_GSb1Cyq05wKwJOQ2 content esgSubNav
In This List

Arch Therapeutics to raise $2.5M via registered direct offering of units

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Arch Therapeutics to raise $2.5M via registered direct offering of units

Arch Therapeutics Inc. plans to raise about $2.5 million in gross proceeds via a registered direct offering of units.

The Framingham, Mass.-based biotechnology plans to sell 14,285,714 units at 17.5 cents apiece. Each unit consists of one common share and one warrant to purchase a common share of the company. The warrants come with an exercise price of 22 cents and are valid for five years from the issuance date.

The offering is expected to close on or about Oct. 18.

The company plans to use the net proceeds from the offering for working capital and general corporate purposes.

H.C. Wainwright & Co. is the exclusive placement agent for the offering.